Cannabidiol for at risk for psychosis youth: A randomized controlled trial.
Günther P AmmingerAshleigh LinMelissa KerrAmber WellerJessica SparkCharlotte PughSally O'CallaghanMaximus BergerScott R ClarkJames G ScottAndrea BakerIain McGregorDavid CotterZoltan SarnyaiAndrew ThompsonAlison R YungO'Donoghue BrianEoin KillackeyCathy MihalopoulosHok Pan YuenBarnaby NelsonPatrick D McGorryPublished in: Early intervention in psychiatry (2021)
This paper reports on the rationale and protocol of the Cannabidiol for At Risk for psychosis Youth (CanARY) study. This study will test CBD for the first time in the UHR phase of psychotic disorder.